Channel:  The Michael J. Fox Foundation

187 Articles

Most recent first Previous |  Page 13: Articles 121-130  | Next

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
Mollenhauer, B., Dakna, M., Liu, T.-Y., Galasko, D., Foroud, T., Zetterberg, H., Schade, S., Gera, R., Wang, W., Gao, F., Kruse, N., Frasier, M., Chahine, L., Coffey, C. S., Singleton, A. B., Simuni, T., Weintraub, D., Seibyl, J., Toga, A. W., Tanner, C. M., Kieburtz, K., Marek, K., Siderowf, A., Cedarbaum, J. M., Hutten, S. J., Trenkwalder, C., Graham, D.
10.1101/762237 — Posted: 2019-12-10
DeepSleep: Fast and Accurate Delineation of Sleep Arousals at Millisecond Resolution by Deep Learning
Li, H., Guan, Y.
10.1101/859256 — Posted: 2019-11-29
Leopard: fast decoding cell type-specific transcription factor binding landscape at single-nucleotide resolution
Li, H., Guan, Y.
10.1101/856823 — Posted: 2019-11-27
Integrated Proteomics Reveals Brain-Based Cerebrospinal Fluid Biomarkers in Asymptomatic and Symptomatic Alzheimer’s Disease
Higginbotham, L., Ping, L., Dammer, E. B., Duong, D. M., Zhou, M., Gearing, M., Johnson, E. C. B., Hajjar, I., Lah, J. J., Levey, A. I., Seyfried, N. T.
10.1101/806752 — Posted: 2019-11-12
The in situ structure of Parkinson’s disease-linked LRRK2
Watanabe, R., Buschauer, R., Boehning, J., Audagnotto, M., Lasker, K., Lu, T. W., Boassa, D., Taylor, S., Villa, E.
10.1101/837203 — Posted: 2019-11-10
Dopamine buffering capacity imaging: A pharmacodynamic fMRI method for staging Parkinson disease
Black, K. J., Acevedo, H. K., Koller, J. M.
10.1101/817106 — Posted: 2019-11-07
Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in non-human primates
Bourdenx, M., Nioche, A., Dovero, S., Arotcarena, M.-L., Camus, S., Porras, G., Thiolat, M.-L., Rougier, N. P., Prigent, A., Aubert, P., Bohic, S., Sandt, C., Laferriere, F., Doudnikoff, E., Kruse, N., Mollenhauer, B., Novello, S., Morari, M., Leste-Lasserre, T., Trigo Damas, I., Goillandeau, M., Perier, C., Estrada, C., Garcia Carrillo, N., Recasens, A., Vaikath, N. N., El-Agnaf, O. M. A., Herrero Ezquerro, M. T., Derkinderen, P., Vila Bover, M., Obeso, J. A., Dehay, B., Bezard, E.
10.1101/825216 — Posted: 2019-10-31
Accurate MS-based Rab10 phosphorylation stoichiometry determination as readout for LRRK2 activity in Parkinson’s disease
Karayel, O., Tonelli, F., Virreira Winter, S., Geyer, P. E., Fan, Y., Sammler, E. M., Alessi, D. R., Steger, M., Mann, M.
10.1101/819607 — Posted: 2019-10-25
No genetic evidence for involvement of alcohol dehydrogenase genes in risk for Parkinson’s disease
Kim, J. J., Bandres Ciga, S., Blauwendraat, C., International Parkinson's Disease Genomics Consortium, , Gan-Or, Z.
10.1101/784405 — Posted: 2019-10-03
Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson’s Disease
Sellnow, R. C., Steece-Collier, K., Altwal, F., Sandoval, I. M., Kordower, J. H., Collier, T. J., Sortwell, C. E., West, A. R., Manfredsson, F.
10.1101/768374 — Posted: 2019-09-28

RSS  Channel RSS